Your browser doesn't support javascript.
loading
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.
Signoriello, Elisabetta; Lus, Giacomo; Bonavita, Simona; Lanzillo, Roberta; Saccà, Francesco; Landi, Doriana; Frau, Jessica; Baroncini, Damiano; Zaffaroni, Mauro; Maniscalco, Giorgia Teresa; Curti, Erica; Sartori, Arianna; Cepparulo, Simone; Marfia, Girolama Alessandra; Nicoletti, Carolina Gabri; Carotenuto, Antonio; Nociti, Viviana; Caleri, Francesca; Sormani, Maria Pia; Signori, Alessio.
Afiliación
  • Signoriello E; Multiple Sclerosis Center, Second Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Lus G; Multiple Sclerosis Center, Second Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Bonavita S; Multiple Sclerosis Center, Second Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Lanzillo R; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
  • Saccà F; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
  • Landi D; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
  • Frau J; Centro Sclerosi Multipla, ASSL Cagliari (ATS Sardegna)/Dipartimento di Scienze Mediche e Sanità Pubblica, University of Cagliari, Cagliari, Italy.
  • Baroncini D; Multiple Sclerosis Center, ASST della Valle Olona, Hospital of Gallarate, Gallarate, Italy.
  • Zaffaroni M; Multiple Sclerosis Center, ASST della Valle Olona, Hospital of Gallarate, Gallarate, Italy.
  • Maniscalco GT; Multiple Sclerosis Center, 'A. Cardarelli' Hospital, Naples, Italy.
  • Curti E; Multiple Sclerosis Center, Neurology Unit, University Hospital of Parma, Parma, Italy.
  • Sartori A; Multiple Sclerosis Center, Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, ASUGI, University of Trieste, Trieste, Italy.
  • Cepparulo S; Multiple Sclerosis Center, Second Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Marfia GA; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
  • Nicoletti CG; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
  • Carotenuto A; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
  • Nociti V; Multiple Sclerosis Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Caleri F; Neurology Department, F. Tappeiner Hospital Meran (BZ), Meran, Italy.
  • Sormani MP; Department of Health Sciences, University of Genova, Genova, Italy.
  • Signori A; Department of Health Sciences, University of Genova, Genova, Italy.
Mult Scler ; 28(1): 93-101, 2022 01.
Article en En | MEDLINE | ID: mdl-33855897

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Italia